NeuroStar TMS and the Future of MDD Treatment for Adolescents
What does the recent FDA clearance of this treatment for adolescents mean for the future of MDD treatment?
Stay updated with breaking news from Kenneth Pages. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
What does the recent FDA clearance of this treatment for adolescents mean for the future of MDD treatment?
This treatment is now the first and only TMS treatment that is FDA-cleared for this patient population.
NeuroStar is the first and only TMS therapy cleared as an adjunct treatment for patients ages 15 and olderMALVERN, Pa., March 25, 2024 -- Neuronetics, Inc. , a medical technology company focused on...
The Company expands technology for patients with obsessive-compulsive disorderMALVERN, Pa., June 12, 2023 -- Neuronetics, Inc. , a medical technology company focused on designing, developing, and... | June 12, 2023
3quarksdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from 3quarksdaily.com Daily Mail and Mail on Sunday newspapers.